ADMA BIOLOGICS, INC. Intangible Assets, Net (Excluding Goodwill)
ADMA BIOLOGICS, INC. (ADMA) had Intangible Assets, Net (Excluding Goodwill) of $575.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-05
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $575.00K.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $630.00K.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $632.00K.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $491.00K.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $575.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $630.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $632.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $491.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $527.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $452.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $460.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | $485.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $479.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $321.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $499.00K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $476.90K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $655.74K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $834.58K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.01M 10-K · filed 2024-02-28 | $1.01M 10-K · filed 2023-03-23 |
| 2022-09-30 | $1.19M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.37M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $1.55M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.73M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $1.91M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.09M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $2.27M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.44M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $2.62M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.80M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.98M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $3.16M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $3.37M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $3.58M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.79M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $4.00M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $4.22M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $4.43M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $4.64M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $4.85M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $5.74M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $6.01M 10-Q · filed 2017-08-11 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |